Literature DB >> 23754611

[T1 bladder cancer: role of documentation for bladder tumor findings and targeted second resection].

D A Lazica1, S Böttcher, S Degener, F-C von Rundstedt, A S Brandt, S Störkel, S Roth.   

Abstract

BACKGROUND: For control resection of T1 bladder tumors an exact relocalization of the previously infiltrating tumor spread can be complicated by postreactive alterations, multiple scar tissue or change of surgeons. In this study the results of control transurethral resection of the bladder (TURB) after T1 high grade bladder tumors with the focus on localization and importance of standardized exact documentation were analyzed. PATIENTS AND METHODS: From July to February 2012 a control resection was performed in 167 patients due to a T1 high grade bladder cancer. The rates of residual tumor tissue and localization were investigated with standardized tumor documentation.
RESULTS: Out of 167 patients with T1 bladder cancer who underwent a control resection tumor tissue was found in 58.1 % (97 out of 167) and in 85.6 % (83 out of 97) the primary site was affected (41.2 % only at primary site and 44.3 % additionally at other locations). In 11 patients (11.3 %) residual tumor tissue at the initial site was only detected histologically.
CONCLUSIONS: Our results indicate that T1 high grade bladder cancers show a relevant rate of residual tumor tissue at control resection which confirms the clinical guidelines of the European Association of Urology (EAU) on mandatory resection. In most cases the primary tumor site is affected. The standardized bladder tumor documetation allows well-directed control resection also in patients with multiple scars and post-TUR alterations, even when performed by a different surgeon.

Entities:  

Mesh:

Year:  2013        PMID: 23754611     DOI: 10.1007/s00120-013-3206-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  10 in total

1.  Histopathological "self control" in transurethral resection of bladder tumours.

Authors:  Z Kolozsy
Journal:  Br J Urol       Date:  1991-02

2.  The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.

Authors:  Mario Richterstetter; Bernd Wullich; Kerstin Amann; Lothar Haeberle; Dirk Gerhard Engehausen; Peter Juergen Goebell; Frens Steffen Krause
Journal:  BJU Int       Date:  2012-02-07       Impact factor: 5.588

Review 3.  Restaging transurethral resection of bladder tumor for high-risk stage Ta and T1 bladder cancer.

Authors:  Miguel Ramírez-Backhaus; José Domínguez-Escrig; Argimiro Collado; José Rubio-Briones; Eduardo Solsona
Journal:  Curr Urol Rep       Date:  2012-04       Impact factor: 3.092

4.  Mechanisms of recurrence of Ta/T1 bladder cancer.

Authors:  Richard T Bryan; Stuart I Collins; Mark C Daykin; Maurice P Zeegers; K K Cheng; D Michael A Wallace; Graham M Sole
Journal:  Ann R Coll Surg Engl       Date:  2010-06-01       Impact factor: 1.891

5.  The value of a second transurethral resection for T1 bladder cancer.

Authors:  Hartwig E Schwaibold; Sivaprakasam Sivalingam; Florian May; Rudolf Hartung
Journal:  BJU Int       Date:  2006-03-23       Impact factor: 5.588

6.  The value of a second transurethral resection in evaluating patients with bladder tumors.

Authors:  H W Herr
Journal:  J Urol       Date:  1999-07       Impact factor: 7.450

7.  Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?

Authors:  A Brauers; R Buettner; G Jakse
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

8.  Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study.

Authors:  Marc-Oliver Grimm; Christine Steinhoff; Xenia Simon; Philipp Spiegelhalder; Rolf Ackermann; Thomas Alexander Vogeli
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

9.  [Predictors for presence of residual tumor in follow-up transurethral resection of bladder tumors: single center results].

Authors:  J Hartinger; R Häußermann; P Olbert; R Hofmann; A Hegele
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

Review 10.  An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer.

Authors:  Girish S Kulkarni; Oliver W Hakenberg; Juergen E Gschwend; George Thalmann; Wassim Kassouf; Ashish Kamat; Alexandre Zlotta
Journal:  Eur Urol       Date:  2009-09-01       Impact factor: 20.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.